Log in to save to my catalogue

Serum RIPK1, Acute Lung Injury, and Outcomes in Severe Traumatic Brain Injury: A Multicenter Prospec...

Serum RIPK1, Acute Lung Injury, and Outcomes in Severe Traumatic Brain Injury: A Multicenter Prospec...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb0f9dbc19cc464ea7c9206f704512fe

Serum RIPK1, Acute Lung Injury, and Outcomes in Severe Traumatic Brain Injury: A Multicenter Prospective Study

About this item

Full title

Serum RIPK1, Acute Lung Injury, and Outcomes in Severe Traumatic Brain Injury: A Multicenter Prospective Study

Publisher

New Zealand: Dove

Journal title

Therapeutics and clinical risk management, 2025-01, Vol.21, p.385-405

Language

English

Formats

Publication information

Publisher

New Zealand: Dove

More information

Scope and Contents

Contents

Receptor-interacting protein kinase-1 (RIPK1), a regulator of necroptosis, is involved in acute brain injury and acute lung injury (ALI). Here, serum RIPK1 levels were measured after severe traumatic brain injury (sTBI), with an endeavor to unveil its prognostic implications and mediation effects of ALI.
In this multicenter prospective study, se...

Alternative Titles

Full title

Serum RIPK1, Acute Lung Injury, and Outcomes in Severe Traumatic Brain Injury: A Multicenter Prospective Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cb0f9dbc19cc464ea7c9206f704512fe

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb0f9dbc19cc464ea7c9206f704512fe

Other Identifiers

ISSN

1176-6336,1178-203X

E-ISSN

1178-203X

DOI

10.2147/TCRM.S502775

How to access this item